Litcius/Paper detail

A fourth dose of the mRNA-1273 SARS-CoV-2 vaccine improves serum neutralization against the Delta variant in kidney transplant recipients

Iliès Benotmane, Timothée Bruel, Delphine Planas, Samira Fafi‐Kremer, Olivier Schwartz, Sophie Caillard

2022Kidney International55 citationsDOIOpen Access PDF

Topics & Concepts

NeutralizationMedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Virology2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)KidneyKidney transplantKidney transplantationMessenger RNAImmunologyInternal medicineVirusBiologyInfectious disease (medical specialty)GeneOutbreakGeneticsDiseaseSARS-CoV-2 and COVID-19 ResearchViral gastroenteritis research and epidemiologyAnimal Virus Infections Studies
A fourth dose of the mRNA-1273 SARS-CoV-2 vaccine improves serum neutralization against the Delta variant in kidney transplant recipients | Litcius